Volume 16 - Issue 5 - May 2003
I am occasionally asked why I write this column. The answer is simple. Writing fulfills my need to engage in an activity where if I screw up and make mistakes, there are no dire consequences and nobody gets hurt. At times, I overstate an opinion and a fellow DPM gets mad but that doesn’t count.
There are aspects of my life in which it is more imperative to avoid mistakes. I’m a husband and father. I’m a doctor. I’m an instrument rated pilot. If I make mistakes in these roles, people can get hurt. I am responsible not to let mistakes occur and to pay the consequences if they do.
New Products »
When treating those who suffer from athlete’s foot, you may want to consider a new lotion that combines two ingredients to offer relief.
The topical lotion deFEET® uses the advanced transdermal drug delivery system of PENtoCORE, which facilitates deeper penetration of the active ingredient of tolnaftate.
BioChemics, the manufacturer of the product, says deFEET relieves athlete’s foot infection and itchy, scaly, burning feet.
In fact, a clinical trial at the New England Medical Center showed that deFEET cured 100 percent of patients in 10 days, according to the
News and Trends »
Is total contact casting (TCC) too time-consuming a modality to be used in treating plantar foot ulcerations? It’s a prevailing question that has thwarted wider use of the modality. However, a new study recently presented at the Symposium on Advanced Wound Care (SAWC) attempts to shed new light on the “time-effectiveness” of TCC.
Study researchers concede there is a “relatively low use rate” of total contact casts for diabetic foot ulcers. Why? They say many do not use TCC because of the time involved in the process and frequent office visits. However, previous studies have shown th
Surgical Pearls »
One of the most commonly performed procedures in the foot is an implant arthroplasty of the first metatarsophalangeal (MPJ) joint. However, we have occasionally noted a hollow medullary canal after resecting the base of the proximal phalanx. This can cause problems with incorporation of the implant. Yet there is an intraoperative option one can use to address this problem.
Adequate bone stock of the proximal phalanx is crucial for proper seating of the hemi-implant. In some cases, we have found the cancellous bone to be cystic with liquefied fat. However, there has been no evidence of cortica
Technology In Practice »
Caring for your patients is a full-time job unto itself. Dealing with managed care and the business end of your practice is another full-time job. Indeed, claims processing and billing issues can be overwhelming at times. However, there are office management systems and software that can help you and your staff stay organized and efficient.
One out of every three podiatrists uses the Wisdom/32 Podiatry Practice Management System, according to VitalWorks, the manufacturer of the software program. It says the Windows-based software offers a variety of helpful options.
Not only can it help w
Heel pain, especially pain associated with the plantar aponeurosis, is one of the most common overuse injuries affecting adults. Approximately 10 percent of runners as well as many other athletes are affected by plantar fasciitis.1 Conservative estimates have suggested more than 2 million Americans annually receive treatment for this condition.1 As common as this injury may be, there is no universally accepted etiology or treatment for this complaint.
In addition to having a strong anatomical grasp of the heel (see “A Guide To Key Anatomical Considerations” below), i
- « Previous
- | Page 1 of 3 |
- Next »